Exact Mass: 438.0639

Exact Mass Matches: 438.0639

Found 26 metabolites which its exact mass value is equals to given mass value 438.0639, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Remimazolam

methyl 3-[(7S)-12-bromo-3-methyl-9-(pyridin-2-yl)-2,5,8-triazatricyclo[8.4.0.0^{2,6}]tetradeca-1(14),3,5,8,10,12-hexaen-7-yl]propanoate

C21H19BrN4O2 (438.0691)


N - Nervous system > N05 - Psycholeptics > N05C - Hypnotics and sedatives > N05CD - Benzodiazepine derivatives C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

Polyozellin

Polyozellin

C22H14O10 (438.0587)


   

Epicorazine C

Epicorazine C

C18H18N2O7S2 (438.0555)


   

Epicoccin E

Epicoccin E

C18H18N2O7S2 (438.0555)


   

Bartramic acid

Bartramic acid

C22H14O10 (438.0587)


   

Pestalone

Pestalone

C21H20Cl2O6 (438.0637)


   

Met-Phe4Cl-OH

(S)-3-(4-chlorophenyl)-2-(3-(2-(methylthio)ethoxy)-4-nitrobenzamido)propanoic acid

C19H19ClN2O6S (438.0652)


   

Phe4Cl-Met-OH

(S)-2-(3-((4-chlorobenzyl)oxy)-4-nitrobenzamido)-5-(methylthio)pentanoic acid

C19H19ClN2O6S (438.0652)


   

n-(8-maleimidocapryloxy)sulfosuccinimide, sodium salt

n-(8-maleimidocapryloxy)sulfosuccinimide, sodium salt

C16H19N2NaO9S (438.0709)


   

2,6-Dichloro-3-(tributylstannyl)pyrazine

2,6-Dichloro-3-(tributylstannyl)pyrazine

C16H28Cl2N2Sn (438.0651)


   

5-(2,4-difluorophenyl)-2-hydroxy-N-[4-nitro-3-(trifluoromethyl)phenyl]benzamide

5-(2,4-difluorophenyl)-2-hydroxy-N-[4-nitro-3-(trifluoromethyl)phenyl]benzamide

C20H11F5N2O4 (438.0639)


   

EMMPNTF2

EMMPNTF2

C11H20F6N2O5S2 (438.0718)


   

CNS-7056

Remimazolam

C21H19BrN4O2 (438.0691)


N - Nervous system > N05 - Psycholeptics > N05C - Hypnotics and sedatives > N05CD - Benzodiazepine derivatives C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

3-[4-[(4,6-Dioxo-2-sulfanylidene-1,3-diazinan-5-ylidene)methyl]-3-(2-oxo-1-benzopyran-3-yl)-1-pyrazolyl]propanoic acid

3-[4-[(4,6-Dioxo-2-sulfanylidene-1,3-diazinan-5-ylidene)methyl]-3-(2-oxo-1-benzopyran-3-yl)-1-pyrazolyl]propanoic acid

C20H14N4O6S (438.0634)


   

3-chloranyl-N-[3-[[[(E)-(3-nitro-6-oxidanylidene-cyclohexa-2,4-dien-1-ylidene)methyl]amino]carbamoyl]phenyl]benzamide

3-chloranyl-N-[3-[[[(E)-(3-nitro-6-oxidanylidene-cyclohexa-2,4-dien-1-ylidene)methyl]amino]carbamoyl]phenyl]benzamide

C21H15ClN4O5 (438.0731)


   

1-[[1-[(3-Chlorophenyl)methyl]-2-oxo-3-indolylidene]amino]-3-(2-fluorophenyl)thiourea

1-[[1-[(3-Chlorophenyl)methyl]-2-oxo-3-indolylidene]amino]-3-(2-fluorophenyl)thiourea

C22H16ClFN4OS (438.0717)


   

1-(4-Bromophenyl)sulfonyl-4-[(3-methoxyphenyl)methyl]-1,4-diazepane

1-(4-Bromophenyl)sulfonyl-4-[(3-methoxyphenyl)methyl]-1,4-diazepane

C19H23BrN2O3S (438.0613)


   

7-Chloro-2-(1-hydroxy-3-methoxy-4-oxocyclohexa-2,5-dien-1-yl)-3,5,6,8-tetramethoxychromen-4-one

7-Chloro-2-(1-hydroxy-3-methoxy-4-oxocyclohexa-2,5-dien-1-yl)-3,5,6,8-tetramethoxychromen-4-one

C20H19ClO9 (438.0718)


   

3-[4-[(E)-3-(4-Bromophenyl)-3-oxoprop-1-enyl]-3-(4-methylphenyl)pyrazol-1-yl]propanoic acid

3-[4-[(E)-3-(4-Bromophenyl)-3-oxoprop-1-enyl]-3-(4-methylphenyl)pyrazol-1-yl]propanoic acid

C22H19BrN2O3 (438.0579)


   

2-(3,5-dichloro-2-hydroxy-6-methoxy-4-methylbenzoyl)-4,6-dihydroxy-3-(3-methylbut-2-en-1-yl)benzaldehyde

2-(3,5-dichloro-2-hydroxy-6-methoxy-4-methylbenzoyl)-4,6-dihydroxy-3-(3-methylbut-2-en-1-yl)benzaldehyde

C21H20Cl2O6 (438.0637)


   

(1r,4s,5r,6r,7s,9r,11r,14s,15r,16r,19r)-5,6,15-trihydroxy-21,22-dithia-3,13-diazaheptacyclo[14.4.1.1⁷,¹¹.0¹,¹³.0³,¹¹.0⁴,⁹.0¹⁴,¹⁹]docosane-2,8,12,18-tetrone

(1r,4s,5r,6r,7s,9r,11r,14s,15r,16r,19r)-5,6,15-trihydroxy-21,22-dithia-3,13-diazaheptacyclo[14.4.1.1⁷,¹¹.0¹,¹³.0³,¹¹.0⁴,⁹.0¹⁴,¹⁹]docosane-2,8,12,18-tetrone

C18H18N2O7S2 (438.0555)


   

5,15,16-trihydroxy-21,22-dithia-3,13-diazahexacyclo[9.9.2.0¹,¹³.0³,¹¹.0⁴,⁹.0¹⁴,¹⁹]docos-6-ene-2,8,12,18-tetrone

5,15,16-trihydroxy-21,22-dithia-3,13-diazahexacyclo[9.9.2.0¹,¹³.0³,¹¹.0⁴,⁹.0¹⁴,¹⁹]docos-6-ene-2,8,12,18-tetrone

C18H18N2O7S2 (438.0555)


   

2-[2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxochromen-8-yl]-3,4-dihydroxybenzoic acid

2-[2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxochromen-8-yl]-3,4-dihydroxybenzoic acid

C22H14O10 (438.0587)


   

(4s,5s,9s,14s,15r,16s,19r)-5,15,16-trihydroxy-21,22-dithia-3,13-diazahexacyclo[9.9.2.0¹,¹³.0³,¹¹.0⁴,⁹.0¹⁴,¹⁹]docos-6-ene-2,8,12,18-tetrone

(4s,5s,9s,14s,15r,16s,19r)-5,15,16-trihydroxy-21,22-dithia-3,13-diazahexacyclo[9.9.2.0¹,¹³.0³,¹¹.0⁴,⁹.0¹⁴,¹⁹]docos-6-ene-2,8,12,18-tetrone

C18H18N2O7S2 (438.0555)


   

5,6,15-trihydroxy-21,22-dithia-3,13-diazaheptacyclo[14.4.1.1⁷,¹¹.0¹,¹³.0³,¹¹.0⁴,⁹.0¹⁴,¹⁹]docosane-2,8,12,18-tetrone

5,6,15-trihydroxy-21,22-dithia-3,13-diazaheptacyclo[14.4.1.1⁷,¹¹.0¹,¹³.0³,¹¹.0⁴,⁹.0¹⁴,¹⁹]docosane-2,8,12,18-tetrone

C18H18N2O7S2 (438.0555)


   

(1s,4r,5s,6s,7r,9s,11s,14r,15s,16s,19s)-5,6,15-trihydroxy-21,22-dithia-3,13-diazaheptacyclo[14.4.1.1⁷,¹¹.0¹,¹³.0³,¹¹.0⁴,⁹.0¹⁴,¹⁹]docosane-2,8,12,18-tetrone

(1s,4r,5s,6s,7r,9s,11s,14r,15s,16s,19s)-5,6,15-trihydroxy-21,22-dithia-3,13-diazaheptacyclo[14.4.1.1⁷,¹¹.0¹,¹³.0³,¹¹.0⁴,⁹.0¹⁴,¹⁹]docosane-2,8,12,18-tetrone

C18H18N2O7S2 (438.0555)